Renaissance Technologies’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,300
Closed -$110K 3789
2020
Q2
$110K Buy
+10,300
New +$110K ﹤0.01% 3262
2018
Q3
Sell
-6,900
Closed -$205K 3627
2018
Q2
$205K Buy
6,900
+340
+5% +$10.1K ﹤0.01% 3070
2018
Q1
$230K Buy
6,560
+1,300
+25% +$45.6K ﹤0.01% 3149
2017
Q4
$227K Buy
+5,260
New +$227K ﹤0.01% 3097